Indefinite Delivery Contract 36E79725D0002

Award Date 12/20/24
Last Date to Order 12/19/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The $29,031,544.57 IDC covers the delivery of a wide range of branded and generic pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service through August 2029. Key items include medications such as ibuprofen, citalopram, albuterol,...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract, valued at a ceiling of $12,802,166.10, is for the delivery of Ramipril capsules in various strengths and package sizes. The period of performance is from March 14, 2022, to March 13, 2023, with four one-year option periods. The...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a division of the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $18,098,362.00 and a period of performance from March 2, 2021 to March 1, 2026. The contract is for the delivery of Pregabalin capsules, a generic pharmaceutical product, to the...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes...
The Department of Veterans Affairs (VA) National Acquisition Center awarded Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, a single-award Indefinite Delivery Contract (IDC) for the supply of pharmaceutical products, including ibuprofen, under the agency's Pharmaceutical Repackaging Program. The contract has a ceiling value of $15,582,998.52 and a period of performance from June 20, 2022 to June 19, 2025. Under this IDC, the VA has issued multiple firm...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract is valued at a ceiling of $52,330,802.25 and has a period of performance from June 15, 2020 to June 14, 2025, including a base year and four one-year option periods. The contract is for the supply of Diclofenac NA 1% Gel...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,164,262.95 and a period of performance from February 22, 2024 to February 21, 2026. The purpose of this contract is to procure oseltamivir phosphate capsules and suspension for distribution to the VA, Department of Defense...

The Indefinite Delivery Contract (IDC) with award ID 36E79725D0002 was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc. for the provision of a wide range of branded and generic pharmaceutical products and services. This single-award IDC has a ceiling value of $4,792,297.44 and a period of performance running through December 19, 2025.

Exelan Pharmaceuticals, a foreign-owned for-profit pharmaceutical company, will supply prescription drugs, over-the-counter medications, and repackaging services to support the healthcare needs of veterans, military personnel, and other federal beneficiaries through the VA's and Department of Defense's (DoD) Pharmaceutical Prime Vendor Programs. The contract covers products such as ibuprofen, citalopram, albuterol, lisinopril, pregabalin, escitalopram oxalate, oseltamivir phosphate, prazosin HCL, sildenafil citrate, and zonisamide. Exelan also provides pharmaceutical repackaging services to the VA's Repackaging Program. This IDC was awarded as an unrestricted procurement without any set-aside designations. The VA National Acquisition Center and the Defense Logistics Agency Troop Support Medical are the primary agencies issuing task orders against this IDC.

Generated 10/22/24, 9:05 AM